Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
21 June 2019 | Story Ruan Bruwer | Photo Ruan Bruwer
Braam van Wyk
Braam van Wyk, hockey high-performance manager at the University of the Free State, should gain valuable experience with the Ghana men’s hockey team.

Braam van Wyk, hockey high-performance manager at the University of the Free State (UFS), wants to plough back whatever he can at international level.

Van Wyk has been appointed as assistant coach of the Ghana men’s hockey team. It is only a part-time appointment, as they don’t play that many matches in a year. Ghana is ranked 35th in the world.  

He will assist the team in the run-up to the Africa Cup in August 2019, where they hope to perform well enough to get an opportunity to play in the Road to Tokyo qualifier for next year’s Olympic Games. 

Van Wyk currently coaches the Ghana players who are based in South Africa. 

“I see this as an opportunity to develop the players, but also for me as a coach to grow and to coach at international level. I am excited to try and add value. The plan is to implement it here at the UFS,” Van Wyk said.

He is also the head coach of the UFS men’s team since 2016, as well as the astro manager.

Learned a lot from coach dad

According to Van Wyk (32), who studied environmental management, he already started coaching in his first year of studies while he was still playing. He represented the UFS from 2006 to 2009. 

“Between 2010 and 2015, my focus shifted to umpiring and I officiated in 19 internationals of which five involved the Protea men’s team.” 

His father, also Braam, is never too far away for guidance. Braam Sr is an astute coach who stood at the helm of many teams over the years, including the Kovsie men and women. He also coached his son while he was playing for the UFS.

“While I was playing, I used to ask him a lot of questions. I learned so much from him and still approach him for advice. He has so much experience and has achieved so much.”

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept